Skip to main content

Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults - United States, November 1-December 10, 2022.

Publication ,  Journal Article
Sinclair, AH; Taylor, MK; Weitz, JS; Beckett, SJ; Samanez-Larkin, GR
Published in: MMWR. Morbidity and mortality weekly report
January 2023

Bivalent COVID-19 booster vaccines, developed to protect against both ancestral and Omicron BA.4/BA.5 variants, are recommended to increase protection against SARS-CoV-2 infection and severe disease* (1,2). However, relatively few eligible U.S. adults have received a bivalent booster dose (3), and reasons for low coverage are unclear. An opt-in Internet survey of 1,200 COVID-19-vaccinated U.S. adults was conducted to assess reasons for receiving or not receiving a bivalent booster dose. Participants could select multiple reasons from a list of suggested reasons to report why they had or had not received a bivalent booster dose. The most common reasons cited for not receiving the bivalent booster dose were lack of awareness of eligibility for vaccination (23.2%) or of vaccine availability (19.3%), and perceived immunity against infection (18.9%). After viewing information about eligibility and availability, 67.8% of participants who had not received the bivalent booster dose indicated that they planned to do so; in a follow-up survey 1 month later, 28.6% of these participants reported having received the dose. Among those who had planned to receive the booster dose but had not yet done so, 82.6% still intended to do so. Participants who had still not received the booster dose most commonly reported being too busy to get vaccinated (35.6%). To help increase bivalent booster dose coverage, health care and public health professionals should use evidence-based strategies to convey information about booster vaccination recommendations and waning immunity (4), while also working to increase convenient access.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

MMWR. Morbidity and mortality weekly report

DOI

EISSN

1545-861X

ISSN

0149-2195

Publication Date

January 2023

Volume

72

Issue

3

Start / End Page

73 / 75

Related Subject Headings

  • Vaccines, Combined
  • Vaccination
  • SARS-CoV-2
  • Humans
  • Health Facilities
  • General & Internal Medicine
  • Eligibility Determination
  • COVID-19
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sinclair, A. H., Taylor, M. K., Weitz, J. S., Beckett, S. J., & Samanez-Larkin, G. R. (2023). Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults - United States, November 1-December 10, 2022. MMWR. Morbidity and Mortality Weekly Report, 72(3), 73–75. https://doi.org/10.15585/mmwr.mm7203a5
Sinclair, Alyssa H., Morgan K. Taylor, Joshua S. Weitz, Stephen J. Beckett, and Gregory R. Samanez-Larkin. “Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults - United States, November 1-December 10, 2022.MMWR. Morbidity and Mortality Weekly Report 72, no. 3 (January 2023): 73–75. https://doi.org/10.15585/mmwr.mm7203a5.
Sinclair AH, Taylor MK, Weitz JS, Beckett SJ, Samanez-Larkin GR. Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults - United States, November 1-December 10, 2022. MMWR Morbidity and mortality weekly report. 2023 Jan;72(3):73–5.
Sinclair, Alyssa H., et al. “Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults - United States, November 1-December 10, 2022.MMWR. Morbidity and Mortality Weekly Report, vol. 72, no. 3, Jan. 2023, pp. 73–75. Epmc, doi:10.15585/mmwr.mm7203a5.
Sinclair AH, Taylor MK, Weitz JS, Beckett SJ, Samanez-Larkin GR. Reasons for Receiving or Not Receiving Bivalent COVID-19 Booster Vaccinations Among Adults - United States, November 1-December 10, 2022. MMWR Morbidity and mortality weekly report. 2023 Jan;72(3):73–75.

Published In

MMWR. Morbidity and mortality weekly report

DOI

EISSN

1545-861X

ISSN

0149-2195

Publication Date

January 2023

Volume

72

Issue

3

Start / End Page

73 / 75

Related Subject Headings

  • Vaccines, Combined
  • Vaccination
  • SARS-CoV-2
  • Humans
  • Health Facilities
  • General & Internal Medicine
  • Eligibility Determination
  • COVID-19
  • Adult